Clinical Trials Browser

Phase 2/3 × OTHER × remdesivir × Clear all

NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Phase 2/3 Withdrawn

COVID-19, Lymphoma, Follicular